CiPA Phase II: Automated cell plating, maintenance, and dosing of hiPSC-derived cardiomyocytes with the Maestro APEX MEA workstation

2016SPS Millard Cipa Phase 2
Download

Millard DC, Nicolini AM, Clements M, Parrish C, Ross JD.

Safety Pharmacology Society, 2016

CiPA Phase II: Automated cell plating, maintenance, and dosing of hiPSC-derived cardiomyocytes with the Maestro APEX MEA workstation
Related Resources
The CiPA Microelectrode Array Assay with hSC-Derived Cardiomyocytes: Current Protocol, Future Potential
Comprehensive in vitro Proarrhythmia Assay (CiPA): Pending issues for successful validation and implementation
What is the CiPA myocyte study?
CiPA: Cardiac Safety Studies

Related Products

Maestro Pro Product Image

Maestro Pro

Cardiac Module for Software

Cardiac Module

Envelope
Stay Up to Date With Our Newsletter: